SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bandit19 who wrote (1222)7/21/1999 1:26:00 PM
From: Robert G. Harrell  Read Replies (1) of 1754
 
Thanks Steve,
I literally just finished printing it. For what its worth, I E-mailed the BBC report posted here yesterday(?) to both VISX and LVCI IR people for comment. I hope they have a satisfactory response because my analysis of information I have gleaned from LVCI indicates parabolic growth is still ahead for both companies. I would hate to see a monkey wrench thrown into the works. The article failed to say whether the people had the PRK or LASIK procedure and who did the procedures. It admitted that the people may have had poor night vision before laser vision correction.

Last week I asked LVCI's IR for some info to fill in the blanks in my data. They sent me an Investor's Information Packet which included the May 11 prospectus. (I think this should be available on Edgar.) On page 39 they have a bar graph of quarterly procedure volume worldwide. You can draw in a bar for April '99 going up to 20,000 (actually 19950 from recent press release). If you draw a curve through the tops you get a nice parabola. VISX's growth should approximate LVCI's.

Yesterday, Jim O'Shaughnessy was the guest host on CNBC Squawk Box. He cited a recently published study (I wish he had given the source) which looked at stocks which had tripled in price and found that most had doubled before they tripled. He might even have said that they doubled twice before they tripled. Regardless, this data coupled with the obvious parabolic growth rate of laser vision correction surgery, portends very well for the future stock price for both LVCI and VISX.

Regards,
Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News